Recent advances in therapies for primary myelofibrosis

Primary myelofibrosis (PMF), polycythemia vera (PV) and essential thrombocythemia (ET) form the classical BCR-ABL1-negative myeloproliferative neoplasms (MPNs) that are driven by a constitutive activation of JAK2 signaling. PMF as well as secondary MF (post-ET and post-PV MF) are the most aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Vainchenker, William, Yahmi, Nasrine, Havelange, Violaine, Marty, Caroline, Plo, Isabelle, Constantinescu, Stefan N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty Opinions Ltd 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523375/
https://www.ncbi.nlm.nih.gov/pubmed/37771602
http://dx.doi.org/10.12703/r/12-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523375/
https://www.ncbi.nlm.nih.gov/pubmed/37771602
http://dx.doi.org/10.12703/r/12-23

Ejemplares similares